Dr. Keith Rennier, Scientist, Molecular Bioanalysis
Dr. Keith Rennier has more than 13 years of biomedical research and development expertise in PCR, cell-based assays, signal transduction pathways and flow cytometry. His research has primarily focused on cellular mechanotransduction, tumor immunology and cancer biology.
He earned a PhD in biomedical engineering from Purdue University in 2015. As a postdoctoral research fellow at Washington University in St. Louis, Keith focused on assay development to delineate key oncogenic signaling pathways and immune cell recruitment in human tumors.
After his fellowship, Keith joined Labcorp in 2020. Currently working as part of Labcorp Biopharmaceutical CMC Services' biodistribution group, Keith serves as the scientific point of contact for internal and external GLP/GCP projects and leads the scientific teams to meet client expectations and project deliverables. Keith provides scientific oversight to ensure the successful development, validation and execution of preclinical- and clinical-stage biodistribution and vector shedding studies.